Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:


Last Updated: December 7, 2021

Volunteer for clinical trials for capreomycin sulfate at ClinicalTrialExchange

DrugPatentWatch Database Preview

Capreomycin sulfate - Generic Drug Details

➤ Subscribe for complete access

« Back to Dashboard

What are the generic sources for capreomycin sulfate and what is the scope of patent protection?

Capreomycin sulfate is the generic ingredient in two branded drugs marketed by Akorn, Hisun Pharm Hangzhou, and Mylan Labs Ltd, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for capreomycin sulfate. One supplier is listed for this compound.

Summary for capreomycin sulfate
Recent Clinical Trials for capreomycin sulfate

Identify potential brand extensions & 505(b)(2) entrants

National Institute of Allergy and Infectious Diseases (NIAID)N/A

See all capreomycin sulfate clinical trials

Pharmacology for capreomycin sulfate
Medical Subject Heading (MeSH) Categories for capreomycin sulfate
Anatomical Therapeutic Chemical (ATC) Classes for capreomycin sulfate

US Patents and Regulatory Information for capreomycin sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn CAPASTAT SULFATE capreomycin sulfate INJECTABLE;INJECTION 050095-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Mylan Labs Ltd CAPREOMYCIN SULFATE capreomycin sulfate INJECTABLE;INJECTION 202634-001 Nov 27, 2017 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Hisun Pharm Hangzhou CAPREOMYCIN SULFATE capreomycin sulfate INJECTABLE;INJECTION 204796-001 Oct 18, 2018 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.